Autoimmune mediated regulation of ovarian tumor growth

Gynecologic Oncology

Volumn 124, Issue 1, 2012, Pages 98-104

  Altuntas, Cengiz Z ^a,b   Jaini, Ritika ^a   Kesaraju, Pavani ^a   Jane Wit, Daniel ^a,d   Johnson, Justin M ^a   Covey, Kelly ^b   Flask, Christopher A ^b   Dutertre, Martin ^c,e   Picard, Jean Yves ^c   Tuohy, Vincent K ^a,b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c INSERM   (France)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e SAINT LOUIS HOSPITAL   (France)

Author keywords

Autoimmune; Cancer vaccine; Ovary; Premature ovarian failure

Indexed keywords

FREUND ADJUVANT; INHIBIN A; MUELLERIAN INHIBITING FACTOR; TUMOR ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNITY; CANCER IMMUNIZATION; CANCER PREVENTION; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; GRANULOSA CELL TUMOR; GROWTH INHIBITION; IMMUNOREGULATION; MEDIATOR; MOUSE; NONHUMAN; OVARY TUMOR; PRIORITY JOURNAL; PROMOTER REGION; SIMIAN VIRUS 40; TRANSGENE; TREATMENT OUTCOME; TUMOR GROWTH; TUMOR XENOGRAFT;

AMINO ACID SEQUENCE; ANIMALS; AUTOIMMUNE DISEASES; AUTOIMMUNITY; CANCER VACCINES; CELL GROWTH PROCESSES; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; INHIBINS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MOLECULAR SEQUENCE DATA; OVARIAN NEOPLASMS; PEPTIDE FRAGMENTS;

EID: 83055194243     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2011.09.023     Document Type: Article

References (28)

1. L.J. Old Cancer vaccine collaborative 2002: opening address Cancer Immun 3 Suppl. 1 2003 1 9 (Pubitemid 38813901)
2. Y. Kawakami, S. Eliyahu, C.H. Delgado, P.F. Robbins, L. Rivoltini, and S.L. Topalian Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor Proc Natl Acad Sci U S A 91 1994 3515 3519 (Pubitemid 24139460)
3. M.E. Dudley, J.R. Wunderlich, P.F. Robbins, J.C. Yang, P. Hwu, and D.J. Schwartzentruber Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes Science 298 2002 850 854 (Pubitemid 35231542)
4. E.J. Small, P.F. Schellhammer, C.S. Higano, C.H. Redfern, J.J. Nemunaitis, and F.H. Valone Placebo-controlled phase III trial of immunologic therapy with sipuleucel-T (APC8015) in patients with metastatic, asymptomatic hormone refractory prostate cancer J Clin Oncol 24 2006 3089 3094 (Pubitemid 46638945)
5. K.E. Mayo Inhibin and activin: molecular aspects of regulation and function Trends Endocrinol Metab 5 1994 407 415
6. N.P. Groome, P.J. Illingworth, M. O'Brien, I. Cooke, T.S. Ganesan, and D.T. Baird Detection of dimeric inhibin throughout the human menstrual cycle by two-site enzyme immunoassay Clin Endocrinol 40 1994 717 723 (Pubitemid 24216620)
7. L.M. Halvorson, and A.H. DeCherney Inhibin, activin, and follistatin in reproductive medicine Fertil Steril 65 1996 459 469 (Pubitemid 26069096)
8. T.R. Kumar, Y. Wang, N. Lu, and M.M. Matzuk Follicle stimulating hormone is required for ovarian follicle maturation but not male fertility Nat Genet 15 1997 201 204 (Pubitemid 27061644)
9. C.Z. Altuntas, J.M. Johnson, and V.K. Tuohy Autoimmune targeted disruption of the pituitary-ovarian axis causes premature ovarian failure J Immunol 177 2006 1988 1996 (Pubitemid 44092540)
10. L. Nelson Primary ovarian insufficiency N Engl J Med 360 2009 606 614
11. M. Dutertre, R. Rey, A. Porteu, N. Josso, and J.Y. Picard A mouse Sertoli cell line expressing anti-Mullerian hormone and its type II receptor Mol Cell Endocrinol 136 1997 57 65 (Pubitemid 28073660)
12. M. Dutertre, L. Gouedard, F. Xavier, W.Q. Long, N. di Clemente, and J.Y. Picard Ovarian granulosa cell tumors express a functional membrane receptor for anti-Mullerian hormone in transgenic mice Endocrinology 142 2001 4040 4046 (Pubitemid 32802677)
13. T.M. McCaughtry, T.A. Baldwin, M.S. Wilken, and K.A. Hogquist Clonal deletion of thymocytes can occur in the cortex with no involvement of the medulla J Exp Med 205 2008 2575 2584
14. K.D. Moudgil, and E.E. Sercarz Understanding crypticity is the key to revealing the pathogenesis of autoimmunity Trends Immunol 26 2005 355 359 (Pubitemid 40835840)
15. A. Jemal, R. Siegel, E. Ward, T. Murray, J. Xu, and M.J. Thun Cancer statistics, 2007 CA Cancer J Clin 57 2007 43 46
16. D.C. Connolly, R. Bao, A.Y. Nikitin, K.C. Stephens, T.W. Poole, and X. Hua Female mice chimeric for expression of the simian virus 40 TAg under control of the MISIIR promoter develop epithelial ovarian cancer Cancer Res 63 2003 1389 1397 (Pubitemid 36348722)
17. K.F. Roby, C.C. Taylor, J.P. Sweetwood, Y. Cheng, J.L. Pace, and O. Tawfik Development of a syngeneic mouse model for events related to ovarian cancer Carcinogenesis 21 2000 585 591 (Pubitemid 30214011)
18. P.J. Fuller, S. Chu, S. Fikret, and H.G. Burger Molecular pathogenesis of granulosa cell tumours Mol Cell Endocrinol 191 2002 89 96 (Pubitemid 34578581)
19. P.J. Fuller, and S. Chu Signalling pathways in the molecular pathogenesis of ovarian granulosa cell tumours Trends Endocrinol Metab 15 2004 122 128 (Pubitemid 38445066)
20. D.M. Robertson, H.G. Burger, and P.J. Fuller Inhibin/activin and ovarian cancer Endocr Relat Cancer 11 2004 35 49 (Pubitemid 38419722)
21. A. Perez-Diez, N.T. Joncker, K. Choi, W.F. Chan, C.C. Anderson, and O. Lantz CD4 cells can be more efficient at tumor rejection than CD8 cells Blood 109 2007 5346 5354 (Pubitemid 46890556)
22. A.L. Marzo, R.A. Lake, B.W. Robinson, and B. Scott T-cell receptor transgenic analysis of tumor-specific CD8 and CD4 responses in the eradication of solid tumors Cancer Res 59 1999 1071 1079 (Pubitemid 29135968)
23. B. Ludewig, A.F. Ochsenbein, B. Odermatt, D. Paulin, H. Hengartner, and R.M. Zinkernagel Immunotherapy with dendritic cells directed against tumor antigens shared with normal host cells results in severe autoimmune disease J Exp Med 191 2000 795 804
24. C.L. Langrish, Y. Chen, W.M. Blumenschein, J. Mattson, B. Basham, and J.D. Sedgwick IL-23 drives a pathogenic T cell population that induces autoimmune inflammation J Exp Med 201 2005 233 240 (Pubitemid 40189432)
25. J.L. Gulley, and W.L. Dahut Future directions in tumor immunotherapy: CTLA4 blockade Nat Clin Pract Oncol 4 2007 136 137 (Pubitemid 46358846)
26. X. Zang, and J.P. Allison The B7 family and cancer therapy: costimulation and coinhibition Clin Cancer Res 13 2007 5271 5279 (Pubitemid 47510350)
27. B. Barnett, I. Kryczek, P. Cheng, W. Zou, and T.J. Curiel Regulatory T cells in ovarian cancer: biology and therapeutic potential Am J Reprod Immunol 54 2005 369 377 (Pubitemid 41748714)
28. T.J. Curiel Tregs and rethinking cancer immunotherapy J Clin Invest 117 2007 1167 1174 (Pubitemid 46718401)